These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6961954)

  • 21. Effect of dextran-S (alpha, 1-3 dextran) on the growth of plasmacytomas MOPC-104E and J558.
    Bhoopalam N; Heller P; Meyerstein N; Hall L
    J Immunol; 1980 Oct; 125(4):1454-8. PubMed ID: 6157734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of total-body tumor cells (MOPC 104E). I. Subcutaneous tumor model.
    Ghanta VK; Hiramoto RN
    J Natl Cancer Inst; 1974 Apr; 52(4):1199-202. PubMed ID: 4826588
    [No Abstract]   [Full Text] [Related]  

  • 23. Regression of MOPC 104E plasmacytoma with monoclonal anti-idiotype antibodies.
    Kodama K; Ghanta VK; Hiramoto NS; Hiramoto RN
    J Biol Response Mod; 1989 Aug; 8(4):385-96. PubMed ID: 2754437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phenotypically dominant regulatory mechanism suppresses major histocompatibility complex class II gene expression in a murine plasmacytoma.
    Venkitaraman AR; Culbert EJ; Feldmann M
    Eur J Immunol; 1987 Oct; 17(10):1441-6. PubMed ID: 3500056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Idiotypic profile of the response to phosphorylcholine induced in the absence of the homologous antigen.
    Cammisuli S; Cosenza H
    Eur J Immunol; 1980 Apr; 10(4):299-304. PubMed ID: 6967412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocyte surface membrane immunoglobulin in myeloma. I. M315-bearing T lymphocytes in mice with MOPC-315.
    Gebel HM; Hoover RG; Lynch RG
    J Immunol; 1979 Sep; 123(3):1110-6. PubMed ID: 313945
    [No Abstract]   [Full Text] [Related]  

  • 27. Protection against MOPC-315 plasmacytoma by immunization with C-type particle preparations.
    Kleinman R; Dray S
    Cancer Res; 1978 Jan; 38(1):223-5. PubMed ID: 201375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model of B cell differentiation.
    Lynch RG; Rohrer JW; Odermatt B; Gebel HM; Autry JR; Hoover RG
    Immunol Rev; 1979; 48():45-80. PubMed ID: 94898
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.
    Adler A; Altbaum I
    J Natl Cancer Inst; 1982 Jun; 68(6):963-9. PubMed ID: 6953275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB; Ye QW
    Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoregulation of murine myeloma: isologous immunization with M315 induces idiotype-specific T cells that suppress IgA secretion by MOPC-315 cells in vivo.
    Rohrer JW; Odermatt B; Lynch RG
    J Immunol; 1979 May; 122(5):2011-9. PubMed ID: 87450
    [No Abstract]   [Full Text] [Related]  

  • 32. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro.
    Maloney DG; Kaminski MS; Burowski D; Haimovich J; Levy R
    Hybridoma; 1985; 4(3):191-209. PubMed ID: 3899906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clearance of MOPC-315-tumour immunoglobulin A from the serum of BALB/c mice [proceedings].
    Jackson GD; Lemaitre-Coelho I; Vaerman JP
    Biochem Soc Trans; 1977; 5(5):1576-9. PubMed ID: 923986
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of tumor growth and antibody clone expression by antigen and anti-idiotype antibody ligands with specificity for receptor-binding sites.
    Bell C; Klein E
    Eur J Immunol; 1979 Oct; 9(10):762-8. PubMed ID: 520408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of B-cell I region encoded antigens in T-cell dependent B-cell activation: I region encoded antigen density correlates with idiotype expression.
    Bottomly K; Dunn E
    Ann N Y Acad Sci; 1983; 418():230-9. PubMed ID: 6231878
    [No Abstract]   [Full Text] [Related]  

  • 36. Subpopulations of B cells distinguished by cell surface expression of Ia antigens. Correlation of Ia and idiotype during activation by cloned Ia-restricted T cells.
    Bottomly K; Jones B; Kaye J; Jones F
    J Exp Med; 1983 Aug; 158(2):265-79. PubMed ID: 6193216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo studies of a 2,4,6-trinitrophenyl (TNP)-binding immunoglobulin A (IgA) lymphoma isolated from MOPC-315, a TNP-binding IgA plasmacytoma of BALB/c mice.
    Gebel HM; Autry JR; Rohrer JW; Lynch RG
    J Natl Cancer Inst; 1979 Jan; 62(1):201-11. PubMed ID: 281574
    [No Abstract]   [Full Text] [Related]  

  • 38. A new T cell neoplasm expressing surface anti-DNP activity, developed from the thymus of mice bearing MOPC-315 plasma cell tumors.
    Lahat N; Moroz C
    Adv Exp Med Biol; 1976; 66():477-81. PubMed ID: 1083649
    [No Abstract]   [Full Text] [Related]  

  • 39. F1 hybrid resistance to murine plasmacytoma MOPC-70A: hybrid resistance to MOPC-70A controlled by a locus linked to H-2.
    Kaneko Y; Natsuume-Sakai S; Moriwaki K; Migita S
    J Immunol; 1980 Nov; 125(5):2031-8. PubMed ID: 7430619
    [No Abstract]   [Full Text] [Related]  

  • 40. The allogeneic effect on tumor growth. I. Inhibition of a murine plasmacytoma, MOPC 315, by the graft-vs-host reaction.
    Osborne DP; Katz DH
    J Immunol; 1977 Apr; 118(4):1441-8. PubMed ID: 15034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.